Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$8.48 - $16.84 $1,178 - $2,340
-139 Reduced 75.54%
45 $1,000
Q1 2022

May 02, 2022

BUY
$8.87 - $22.1 $1,632 - $4,066
184 New
184 $3,000
Q3 2021

Oct 28, 2021

SELL
$8.33 - $15.02 $633 - $1,141
-76 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$9.32 - $13.26 $708 - $1,007
76 New
76 $1,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.